Rocket Lab Funds Iridium Deal, Eyes EBITDA Growth
Rocket Lab has cancelled its $3.6 billion bridge loan without drawing on it, and says its planned acquisition of Iridium is now fully funded. Iridium generates about $500 million in annual EBITDA, compared with Rocket Lab’s roughly $80 million EBITDA loss. Combined, the businesses could produce about $420 million in EBITDA before Rocket Lab’s Neutron rocket programme contributes, although this is an estimate rather than a guaranteed outcome.
The transaction could also expand Rocket Lab’s share count by up to 72 million shares. About 17 million of those shares depend on a collar tied to Rocket Lab’s stock price. For traders, the acquisition offers a potential improvement in Rocket Lab’s earnings profile, balanced against execution risks and possible share dilution.
Neutral
This is a corporate-finance and aerospace deal, not a cryptocurrency-market event. It contains no direct information about crypto assets, blockchain projects, token demand, regulation or crypto-market liquidity, so it provides no clear trading catalyst for Bitcoin or other digital assets.
The announcement could affect Rocket Lab’s shares: investors may welcome the prospect of adding Iridium’s recurring earnings, while weighing the acquisition’s execution risks and potential dilution of up to 72 million shares. Similar acquisition announcements often produce company-specific volatility as traders assess financing, integration and valuation. Any broader effect on risk sentiment would likely be limited and indirect. In the short term, crypto traders should not infer a directional signal from this news; over the longer term, it would matter to crypto markets only if it contributed to a wider change in risk appetite or capital allocation, neither of which is established by the article.